Open in interactive viewer → charts, metric popovers & call review

Elmet Buys the Mine, the Refinery and the Pentagon — and the Market Sells the Stock

A $450M Department of War anchor, a $2B DLA ceiling and a German tungsten plant re-shape the company; but 70% of the quarter's growth was price, and the new trading arm is hostage to someone else's mine ramp.
ELMT · Earnings Call · 2026-11-10

The Shape Change

Elmet was, until a few months ago, a roughly half-billion-dollar maker of refractory metals and microwave components with two divisions and a customer list of blue-chip primes. It reported Tuesday as something structurally different: a three-division, government-anchored, vertically integrating critical-materials platform. The Department of War has committed $450 million — the first deal out of the DoW's new Economic Defense Unit — structured as redeemable preferred plus warrants for up to 19.9% of the common, with $200 million drawn at closing. Alongside it sits a $2 billion ceiling DLA contract for tungsten concentrate and sodium tungstate, of which $161.9 million is already funded and now sitting in backlog. And a third leg, a brand-new ERT division (Refining & Trading), is meant to convert that government relationship into a commercial supply business.“a landmark $450 million committed investment from the Department of War; a new $2 billion framework with the Defense Logistics Agency, or DLA, with initial purchase orders of $162 million” — Peter Anania, Chairman and CEO · 2026-11-10To feed it, management is buying the supply chain rather than renting it: $100 million of DoW money plus roughly $25 million of its own into Masan, a UK offtake of more than 1,000 tons a year of Tungsten West concentrate, roughly $150 million earmarked for the Blue Moon Springer complex in Nevada via a $25 million equity stake, a $50 million secured facility and an Elmet-controlled JV — and the planned purchase of ams OSRAM's Schwabmünchen metals operation, which would be Germany's only fully integrated tungsten producer. APT conversion, the chemical step between ore and powder, is the thread tying all of it together.

Seventy Percent Price, Thirty Percent Demand

The numbers were spectacular: revenue up 55.6% to $79.6 million, gross margin from 21.7% to 31.3%, adjusted EBITDA up 129% to $17.0 million, net income $8.3 million or $0.24 per diluted share. But the composition matters more than the headline. Management was unusually candid that roughly 70% of the growth came from tungsten and molybdenum raw material prices, and only 30% from demand — shipments ex-price rose about 15%. Even the margin bridge is mostly market, not muscle:“about 2/3 of that growth going -- so let's say, 600 to 650 basis points is the impact of pricing going up and us, therefore, marking that material up as we sell it through. And then about 1/3 of our margin growth, so in the 300 to 400 basis range, is operational performance” — Michael Lee, Chief Financial Officer · 2026-11-10That distinction is why the trailing-twelve-month view reads so differently from the quarter: revenue up only 12.4% to $257.0 million, gross margin 25.1%, adjusted EBITDA $38.1 million at 14.8% of revenue. The same is true of the backlog explosion — $347.4 million versus $131.5 million at the end of Q2 and $87.3 million a year ago — of which $161.9 million is the DLA award and $52.7 million of the $98.1 million legacy-division growth is explicitly attributed to material pricing. On top of that, tungsten price gains take up to nine months to roll through the P&L, which means the Q1 spike to $3,000 per MTU is still, in the CFO's words, not fully reflected. The next two or three quarters are therefore flattered by a tailwind management cannot re-create.

The Optionality That Belongs to Somebody Else

Here is where the call gets genuinely interesting. The ERT trading business, at full scale and current pricing, could be a "couple of hundred million dollars" of run-rate revenue — a step-change for a company doing $257 million on a TTM basis. But it is entirely dependent on a third party's mine.

there will be a time-phased delay from them starting to ramp and us seeing revenue of depending on how much and how we actually sell it between, I'd say, 3 to 6 months when they start to ramp. So it's hard to pinpoint what the impact to 2027 is because it's not really in our control... At full scale at current pricing, again, the current pricing, we could see a couple of hundred million dollars start to manifest the run rate, maybe a little bit more.

Michael Lee, Chief Financial Officer · 2026-11-10
Note the second-order complexity the CFO flagged: depending on whether the material routes through DLA or through Masan in Vietnam, revenue may be recognised once or twice, over sixty days or several months. And roughly a third to a half of the volume gets consumed internally, further muddying the optics. Meanwhile Schwabmünchen, a genuine strategic asset, is a lighting plant being converted — a turnaround that management concedes will be dilutive to margins before it turns cash-flow positive in year three.

The Flow-Down That Keeps Not Arriving

The most telling moment was the question about new DFARS rules taking effect January 1. Asked what customers are saying, the answer was: not much yet.“we haven't seen a significant uptick in orders distinctly tied to that... it's often these -- especially because there have been some pretty dramatic rules to these NDAAs... that the time for that to be digested in these large primes is a lot longer than you may anticipate.” — Michael Lee, Chief Financial Officer · 2026-11-10That is the same refrain as three months ago, when an analyst asked about the large missile-defense interceptor awards to the primes and got: “We really haven't seen a significant amount of those larger multiyears the primes are being awarded flow down to us yet.” — Michael Lee, CFO · 2026-08-13 Two consecutive quarters of "the wave is coming, it just hasn't broken." Management blames appropriations and prime-contractor digestion; the market hears deferred revenue. What has quietly dropped from the narrative is last quarter's orbital compute thread — the SpaceX and satellite-supply discussion that ate a full Q&A exchange in August is gone, replaced by Peter's note that Echodyne anti-drone work is “expanding rapidly right now” — Peter Anania, Chairman and CEO · 2026-11-10. The previous quarter's candid chatter about a volatile large medical customer also vanished. What replaced it is a much larger, government-brokered story — and a much less controllable one.

Why It Matters

Elmet is riding a genuine, and now widely shared, critical-minerals wave: MP Materials talked heavy rare earth separation, USAR flagged a heavy rare earth value chain, and even 3DA.AX booked a Department of War award this week. That consensus cuts both ways — it validates the thesis and signals that Elmet is no longer the only game in town. Meanwhile the tape has already voted its skepticism: after the late-October run to $24.08, the stock sits 19.5% below that peak into this print, with a 30-day return of -2.9%. The company just told investors its future revenues depend on a UK mine's ramp schedule, that its current margins are two-thirds commodity, and that the defense supercycle is still in the mail. Peter closed with “a time of unprecedented realignment” — Peter Anania, Chairman and CEO · 2026-11-10 — true, but the realignment now runs through permitting, mine ramps and appropriations calendars rather than through Elmet's own factories. That is a very different risk profile than the one that bought the stock in October.